Intermediaries in the Medicare Market

How to cite

Shen, Elaine; Kallus, Margaret. 2024. "Intermediaries in the Medicare Market." AEA RCT Registry. AEARCTR-0014329. https://doi.org/10.1257/rct.14329-6.0

Download: BibTeX · RIS — for reference managers without a browser translator. Zotero and most others pick up this page's citation metadata directly.

Elaine Shen* , Margaret Kallus

* Primary investigator

Registry ID
AEARCTR-0014329
DOI
https://doi.org/10.1257/rct.14329-6.0
First registered
Last updated
Status
In development
Trial dates
2024-10-16 – 2026-10-15
Countries
Private
JEL codes
I13, I18, D14, D18, G41
Registry record
http://www.socialscienceregistry.org/trials/14329

Abstract

This study seeks to understand the role of intermediaries in the Medicare market. Specifically, we investigate how quality of insurance advice is correlated with consumer and agent characteristics.

Experimental design

We will conduct a correspondence study that randomly assigns seniors to call insurance agents for a plan recommendation. We will evaluate whether recommendation quality varies with caller and agent characteristics. Finally, we evaluate whether agent advice is elastic to a randomly assigned “competition” treatment and to different commission/incentive regimes.

Design details

Randomization method
Insurance agents are randomly assigned to treatment or control status by a computer. Consumers are randomly assigned by the secret shopper firm.
Randomization unit
Consumers will be randomly assigned to insurance agents at the individual level. Variation in competition signaling and consumer characteristics such as gender and age will also be randomly assigned.
Clusters
With our current research funding, we expect to be able to collect between 650-950 observations. For additional detail, please see our pre-analysis plan.
Observations
With our current research funding, we expect to be able to collect between 650-950 observations. For additional detail, please see our pre-analysis plan.
Arms
We will aim to have an equal number of observations in our treatment and control arms.
Primary outcomes
The key outcome of interest is the quality of the Medicare plan recommendations from the insurance producer (or insurance broker or agent). We will examine two main outcomes: i) whether or not the agent recommends Medicare Advantage (MA), ii) the difference between the recommended Medicare Supplement (Medigap) plan premium and the lowest-cost Medigap plan premium available to the consumer. For simplicity, we also create a "bad recommendations" index combining these two outcomes into a single metric. We also measure the Medigap outcome two additional ways: iii) the Medigap Agent Markup (the difference between the recommended Medigap premium and the lowest Medigap premium offered by insurance companies the agent is currently appointed with) and iv) the Medigap percent markup (the Medigap Markup as a percent of the price of the lowest-cost identical plan. More specifics on how we measure the primary outcomes are included in our pre-analysis plan.
Secondary outcomes
We will look at whether agents use certain sales tactics and accurately explain important insurance concepts to seniors. More specifics on this are included in our pre-analysis plan.

Cited by

No citation data available for this registration yet.

Keywords